\-\ Texto\\:\\ \ \(0\)\
\-\ asymptomatic\\.\\ \\ initial\\ labs\\ \\(cbc\\/chem\\)\\ wnl\\.\ \(0\)\
\-\ patient\\ is\\ scheduled\\ for\\ lesion\\ resection\\ in\\ august\\ 2004\\.\ \(0\)\
\-\ pa\\/lat\\ cxr\\:\\ \\ there\\ is\\ irregularity\\ to\\ the\\ contour\\ of\\ the\\ right\\ hilum\\ on\\ the\\ pa\\ view\\.\\ \\ on\\ the\\ lateral\\ view\\,\\ there\\ is\\ a\\ central\\,\\ rml\\ nodule\\ which\\ when\\ going\\ back\\ to\\ the\\ pa\\,\\ can\\ barely\\ be\\ seen\\.\ \(0\)\
\-\ axial\\ ct\\:\\ \\ note\\ the\\ round\\,\\ smooth\\ nodule\\ just\\ anterior\\ to\\ the\\ takeoff\\ of\\ the\\ medial\\ rml\\ bronchus\\.\\ \\ there\\ is\\ no\\ calcification\\,\\ and\\ no\\ strong\\ enhancement\\ with\\ intravenous\\ contrast\\.\\ \\ the\\ lesion\\ does\\ not\\ appear\\ to\\ involve\\ the\\ bronchial\\ lumen\\.\\ \\ \ \(0\)\
\-\ coronal\\ ct\\ reformation\\:\\ \\ round\\ nodule\\ superior\\ to\\ the\\ rml\\ bronchus\\ again\\ demonstrated\\.\ \(0\)\
\-\ typical\\ bronchial\\ carcinoid\ \(0\)\
\-\ hilar\\ lad\ \(0\)\
\-\ primary\\ bronchial\\ neoplasm\ \(0\)\
\-\ primary\\ lung\\ neoplasm\ \(1\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ 66yo\\ asymptomatic\\ female\\ with\\ significant\\ past\\ smoking\\ history\\ and\\ abnormal\\,\\ incidental\\ chest\\ finding\\ on\\ routine\\ ebct\\.\ \(0\)\
\-\ the\\ location\\ of\\ this\\ lesion\\ is\\ somewhat\\ more\\ peripheral\\ than\\ is\\ usually\\ seen\\ with\\ typical\\ carcinoids\\.\\ \\ this\\ carcinoid\\ is\\ also\\ \\"atypical\\"\\ in\\ that\\ it\\ does\\ not\\ enhance\\,\\ and\\ is\\ not\\ calcified\\.\\ \\ the\\ pathology\\,\\ however\\,\\ was\\ consistent\\ with\\ a\\ low\\-grade\\ \\(typical\\)\\ bronchial\\ carcinoid\\.\\ \\ this\\ patient\\ fell\\ into\\ the\\ 25\\%\\ of\\ patients\\ who\\ present\\ asymptomatically\\ with\\ the\\ lesion\\ as\\ an\\ incidental\\ finding\\ on\\ another\\ study\\,\\ which\\ in\\ this\\ case\\ was\\ an\\ ebct\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ bronchial\\:\\ 0\\.0831798542560408\ \(0\)\
\-\ rml\\:\\ 0\\.08151002284349997\ \(0\)\
\-\ ebct\\:\\ 0\\.06971992483610776\ \(0\)\
\-\ carcinoid\\:\\ 0\\.0653800275409845\ \(0\)\
\-\ nodule\\:\\ 0\\.045350389689811234\ \(0\)\
\-\ typical\\:\\ 0\\.04411733940965662\ \(0\)\
\-\ bronchus\\:\\ 0\\.04338470650878056\ \(0\)\
\-\ cbc\\/chem\\:\\ 0\\.03783484302131544\ \(0\)\
\-\ reformation\\:\\ 0\\.03783484302131544\ \(0\)\
\-\ 66yo\\:\\ 0\\.03783484302131544\ \(0\)\
\-\ asymptomatically\\:\\ 0\\.03783484302131544\ \(0\)\
\-\ carcinoids\\:\\ 0\\.031885081814792306\ \(0\)\
\-\ round\\:\\ 0\\.03168716261427673\ \(0\)\
\-\ pa\\:\\ 0\\.030676149432676873\ \(0\)\
\-\ lesion\\:\\ 0\\.02988077641202497\ \(0\)\
\-\ takeoff\\:\\ 0\\.029483297317215384\ \(0\)\
\-\ barely\\:\\ 0\\.028404694620730808\ \(0\)\
\-\ incidental\\:\\ 0\\.0277750094247234\ \(0\)\
\-\ view\\:\\ 0\\.027519713551772865\ \(0\)\
\-\ 2004\\.\\:\\ 0\\.026826476680278804\ \(0\)\
\-\ does\\:\\ 0\\.02502679030372538\ \(0\)\
\-\ neoplasm\\:\\ 0\\.024979884771776206\ \(0\)\
\-\ lad\\:\\ 0\\.024977622963143806\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.024794784532155254\ \(0\)\
\-\ going\\:\\ 0\\.02419512701123842\ \(0\)\
\-\ finding\\:\\ 0\\.023640012918785248\ \(0\)\
\-\ pa\\/lat\\:\\ 0\\.023533536110692248\ \(0\)\
\-\ august\\:\\ 0\\.022575838465566885\ \(0\)\
\-\ low\\-grade\\:\\ 0\\.022454933414207675\ \(0\)\
\-\ hilum\\:\\ 0\\.02211140247998649\ \(0\)\
\-\ primary\\:\\ 0\\.021728620282366492\ \(0\)\
\-\ strong\\:\\ 0\\.021310604387366695\ \(0\)\
\-\ irregularity\\:\\ 0\\.019600957862305316\ \(0\)\
\-\ is\\:\\ 0\\.019306121146256672\ \(0\)\
\-\ wnl\\:\\ 0\\.01881846191039993\ \(0\)\
\-\ smoking\\:\\ 0\\.018522355165820743\ \(0\)\
\-\ scheduled\\:\\ 0\\.01847493097617875\ \(0\)\
\-\ hilar\\:\\ 0\\.018428025094066342\ \(0\)\
\-\ intravenous\\:\\ 0\\.01820089032387603\ \(0\)\
\-\ somewhat\\:\\ 0\\.018027458828863686\ \(0\)\
\-\ contour\\:\\ 0\\.017779783645942453\ \(0\)\
\-\ enhance\\:\\ 0\\.017739859213915358\ \(0\)\
\-\ lumen\\:\\ 0\\.01766110754581151\ \(0\)\
\-\ again\\:\\ 0\\.017622267050017872\ \(0\)\
\-\ fell\\:\\ 0\\.017545624915253896\ \(0\)\
\-\ involve\\:\\ 0\\.017287668159589924\ \(0\)\
\-\ this\\:\\ 0\\.016500209670628894\ \(0\)\
\-\ there\\:\\ 0\\.016374020040321742\ \(0\)\
\-\ smooth\\:\\ 0\\.016052981153359104\ \(0\)\
\-\ not\\:\\ 0\\.01589895285504638\ \(0\)\
\-\ atypical\\:\\ 0\\.015894981268712253\ \(0\)\
\-\ another\\:\\ 0\\.015767617456926345\ \(0\)\
\-\ calcified\\:\\ 0\\.015742592047867147\ \(0\)\
\-\ cxr\\:\\ 0\\.015476533352468144\ \(0\)\
\-\ just\\:\\ 0\\.015315426402600911\ \(0\)\
\-\ coronal\\:\\ 0\\.01527048520145372\ \(0\)\
\-\ appear\\:\\ 0\\.015010293691511939\ \(0\)\
\-\ pathology\\:\\ 0\\.015010293691511939\ \(0\)\
\-\ 25\\:\\ 0\\.014825005400244947\ \(0\)\
\-\ routine\\:\\ 0\\.014705779803218872\ \(0\)\
\-\ \\:\\:\\ 0\\.01455289462648925\ \(0\)\
\-\ seen\\:\\ 0\\.01449465764006601\ \(0\)\
\-\ note\\:\\ 0\\.014154787671681504\ \(0\)\
\-\ which\\:\\ 0\\.013692228216674238\ \(0\)\
\-\ calcification\\:\\ 0\\.013312384628571369\ \(0\)\
\-\ peripheral\\:\\ 0\\.01327010009448119\ \(0\)\
\-\ location\\:\\ 0\\.012792736853664777\ \(0\)\
\-\ labs\\:\\ 0\\.012755253248648662\ \(0\)\
\-\ on\\:\\ 0\\.012427313517003057\ \(0\)\
\-\ initial\\:\\ 0\\.012152713061284584\ \(0\)\
\-\ back\\:\\ 0\\.012098997147414066\ \(0\)\
\-\ central\\:\\ 0\\.01206708736849768\ \(0\)\
\-\ study\\:\\ 0\\.01206708736849768\ \(0\)\
\-\ medial\\:\\ 0\\.011730899199957304\ \(0\)\
\-\ superior\\:\\ 0\\.011711346339288374\ \(0\)\
\-\ past\\:\\ 0\\.011653216617795854\ \(0\)\
\-\ \\,\\:\\ 0\\.011618457747523063\ \(0\)\
\-\ resection\\:\\ 0\\.011437406246867891\ \(0\)\
\-\ usually\\:\\ 0\\.011137031132475361\ \(0\)\
\-\ demonstrated\\:\\ 0\\.010761459152175825\ \(0\)\
\-\ lung\\:\\ 0\\.010623000516046121\ \(0\)\
\-\ when\\:\\ 0\\.010503567543416333\ \(0\)\
\-\ axial\\:\\ 0\\.010466916206299878\ \(0\)\
\-\ abnormal\\:\\ 0\\.010459623348991035\ \(0\)\
\-\ ct\\:\\ 0\\.010260117196498223\ \(0\)\
\-\ however\\:\\ 0\\.010211880066940217\ \(0\)\
\-\ an\\:\\ 0\\.010143046045362487\ \(0\)\
\-\ significant\\:\\ 0\\.009862004940146881\ \(0\)\
\-\ enhancement\\:\\ 0\\.009830423888940069\ \(0\)\
\-\ than\\:\\ 0\\.00960965173784667\ \(0\)\
\-\ who\\:\\ 0\\.009562096176573828\ \(0\)\
\-\ patients\\:\\ 0\\.009491736477965777\ \(0\)\
\-\ anterior\\:\\ 0\\.009445462762930203\ \(0\)\
\-\ metastatic\\:\\ 0\\.009232229200069057\ \(0\)\
\-\ more\\:\\ 0\\.009172430512069384\ \(0\)\
\-\ to\\:\\ 0\\.009164551683325885\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.009013455097132262\ \(0\)\
\-\ consistent\\:\\ 0\\.008992696432751945\ \(0\)\
\-\ the\\:\\ 0\\.008900168543151874\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.00884012661794954\ \(0\)\
\-\ chest\\:\\ 0\\.00877566094445287\ \(0\)\
\-\ into\\:\\ 0\\.008726722609269127\ \(0\)\
\-\ \\%\\:\\ 0\\.008555025894188873\ \(0\)\
\-\ was\\:\\ 0\\.00848306886020332\ \(0\)\
\-\ can\\:\\ 0\\.008318550868965964\ \(0\)\
\-\ present\\:\\ 0\\.008283299373097342\ \(0\)\
\-\ it\\:\\ 0\\.00824398448297432\ \(0\)\
\-\ contrast\\:\\ 0\\.008209337711621911\ \(0\)\
\-\ case\\:\\ 0\\.008023624175396012\ \(0\)\
\-\ lateral\\:\\ 0\\.0079256139297191\ \(0\)\
\-\ female\\:\\ 0\\.007539743654282548\ \(0\)\
\-\ no\\:\\ 0\\.007385786701320189\ \(0\)\
\-\ patient\\:\\ 0\\.007352720437050541\ \(0\)\
\-\ also\\:\\ 0\\.007230127011459877\ \(0\)\
\-\ that\\:\\ 0\\.006334681238449886\ \(0\)\
\-\ \\(\\:\\ 0\\.006200529839003094\ \(0\)\
\-\ \\)\\:\\ 0\\.006124787056766568\ \(0\)\
\-\ disease\\:\\ 0\\.005994581721955812\ \(0\)\
\-\ be\\:\\ 0\\.005655608254694975\ \(0\)\
\-\ as\\:\\ 0\\.005547542943751621\ \(0\)\
\-\ in\\:\\ 0\\.005425715409531179\ \(0\)\
\-\ history\\:\\ 0\\.005065298445094779\ \(0\)\
\-\ right\\:\\ 0\\.003869663987598355\ \(0\)\
\-\ a\\:\\ 0\\.003404290144365676\ \(0\)\
\-\ for\\:\\ 0\\.0031292195220717386\ \(0\)\
\-\ with\\:\\ 0\\.0025108192293967755\ \(0\)\
\-\ and\\:\\ 0\\.002317712520157319\ \(0\)\
\-\ of\\:\\ 0\\.002000065249750874\ \(0\)\
\-\ \\.\\:\\ 0\\.0019806608122982902\ \(0\)\
